Speaker illustration

Doctor Hiroaki Ichikawa

Hirosaki University Graduate School of Medicine, Hirosaki (Japan)

Rivaroxaban, a direct factor Xa inhibitor, ameliorates angiotensin II-induced renal damage through inhibition of protease-activated receptor pathway-mediated inflammatory response

Event: ESC CONGRESS 2017

Topic: Basic Science

Session: Cardiovascular care - Biology II

Thumbnail

This platform is supported by

logo Novo Nordisk